Science Today

AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) approved the use of IMBRUVICA (ibrutinib) in combination with obinutuzumab (GAZYVA) for adult patients with previously untreated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). The latest FDA approval expands the use of IMBRUVICA, which can already be administered as a single agent or in combination with bendamustine and rituximab (BR) for adult CLL/SLL patients.1IMBRUVICA is a once-daily, first-in-class Bruton's tyrosine kinase (BTK) inhibitor that is administered orally, and is jointly developed and commercialized by Pharmacyclics LLC, an AbbVie company, and Janssen Biotech, Inc. 'This latest IMBRUVICA FDA approval gives the healthcare community the first chemotherapy-free, anti-CD20 combination to treat CLL and SLL patients who have not yet started therapy. Also, and importantly, this new treatment combination helps red...

Yeah! You guys read it correctly. Actually, this year's GPAT examination was a little bit unpredictable.  Overall the exam was not a walnut shell but on the very far end, it is also true that most of the students were unaware of this type of pattern.  Actually this year NTA conducted GPAT examination on the same facet of other competitive exams. NTA raised several questions directly from the surface but as the students were unaware of such thing, they used to prepare for the exam very similar to last years pattern. A very few students get able to reach that point in the exam that they could say it confidently that they would definitely able to overcome such an exam. Questions were asked from several untouched topics such as Physical chemistry and thermodynamics. Questions from Pharmacognosy were few. Pharmacology also contained some questions from general Anatomy and Physiology. P harmaceutical chemistry was pretty much decent. At the last but not the least I would like to say...

Register yourself here For more information:  Contact Dr. (Mrs.) M. Akhtar  📞 +91 98913 69482

B. Pharm, S.P.E.R, Jamia Hamdard, New Delhi Race With Dreams! © 2015-2016

B. Pharm, S.P.E.R, Jamia Hamdard, New Delhi Race With Dreams! © 2015-2016  Talcum powder can cause cancer!  CANADA IS planning to restrict the use of talc in cosmetics, natural health products and nonprescription drugs. A draft report released by Health Canada, the government department looking after public health, on December 5, 2018, said it found that inhaling loose talc powders can damage the lungs. Using products containing talc in the female genital area, like baby powder, diaper creams and bath bombs is a possible cause of ovarian cancer, the report said. It added that the assessment did not find that ingesting talc in food or drugs or using it in pressed powder cosmetics like eyeshadows and blushes was harmful. The department has asked for comments over the draft findings. In fact, in July 2018, cosmetics manufacturer Johnson & Johnson paid 22 women in the US nearly $4.7 billion in a lawsuit linking baby powder to ovarian cancer. Africa will be sett...